Ethoxyquin, a Lipid Peroxidation Inhibitor, Has Protective Effects against White Matter Lesions in a Mouse Model of Chronic Cerebral Hypoperfusion
Biological and Pharmaceutical Bulletin · 2024
DOI: 10.1248/bpb.b23-00538 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biological and Pharmaceutical Bulletin, 2024. Verfasst von Masami Abe und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Pathobiology, Faculty of Pharmaceutical Sciences, Kyushu University. Hauptthemen laut MEDLINE: Dementia, Vascular, White Matter, Brain Ischemia, Cerebrovascular Disorders. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
White matter lesions induced by chronic cerebral hypoperfusion can cause vascular dementia; however, no appropriate treatments are currently available for these diseases. In this study, we investigated lipid peroxidation, which has recently been pointed out to be associated with cerebrovascular disease and vascular dementia, as a therapeutic target for chronic cerebral hypoperfusion. We used ethoxyquin, a lipid-soluble antioxidant, in a neuronal cell line and mouse model of the disease. The cytoprotective effect of ethoxyquin on glutamate-stimulated HT-22 cells, a mouse hippocampal cell line, was comparable to that of a ferroptosis inhibitor. In addition, the administration of ethoxyquin to bilateral common carotid artery stenosis model mice suppressed white matter lesions, blood-brain barrier disruption, and glial cell activation. Taken together, we propose that the inhibition of lipid peroxidation may be a useful therapeutic approach for chronic cerebrovascular disease and the resulting white matter lesions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Pathobiology, Faculty of Pharmaceutical Sciences, Kyushu University.
Zitieren
APA
Abe, M., Sou, M., Matsuoka, Y., Morimoto, K., & Yamada, K. I. (2024). Ethoxyquin, a Lipid Peroxidation Inhibitor, Has Protective Effects against White Matter Lesions in a Mouse Model of Chronic Cerebral Hypoperfusion. Biological and Pharmaceutical Bulletin. https://doi.org/10.1248/bpb.b23-00538
Vancouver
Abe M, Sou M, Matsuoka Y, Morimoto K, Yamada KI. Ethoxyquin, a Lipid Peroxidation Inhibitor, Has Protective Effects against White Matter Lesions in a Mouse Model of Chronic Cerebral Hypoperfusion. Biological and Pharmaceutical Bulletin. 2024. doi:10.1248/bpb.b23-00538
BibTeX
@article{Abe2024,
author = {Abe, Masami and Sou, Marie and Matsuoka, Yuta and Morimoto, Kazushi and Yamada, Ken-Ichi},
title = {Ethoxyquin, a Lipid Peroxidation Inhibitor, Has Protective Effects against White Matter Lesions in a Mouse Model of Chronic Cerebral Hypoperfusion},
journal = {Biological and Pharmaceutical Bulletin},
year = {2024},
doi = {10.1248/bpb.b23-00538}
}
EUVIMED